181 related articles for article (PubMed ID: 18283287)
1. Progress and prospects: gene therapy for performance and appearance enhancement.
Kiuru M; Crystal RG
Gene Ther; 2008 Mar; 15(5):329-37. PubMed ID: 18283287
[TBL] [Abstract][Full Text] [Related]
2. Displaced agendas: current regulatory strategies for germline gene therapy.
Marden E; Nelkin D
McGill Law J; 2000 May; 45(2):461-81. PubMed ID: 12688283
[TBL] [Abstract][Full Text] [Related]
3. The case against perfection: what's wrong with designer children, bionic athletes, and genetic engineering.
Sandel MJ
Atl Mon; 2004 Apr; 292(3):50-4, 56-60, 62. PubMed ID: 15468473
[No Abstract] [Full Text] [Related]
4. Gene therapy progress and prospects: bringing gene therapy into medical practice: the evolution of international ethics and the regulatory environment.
Spink J; Geddes D
Gene Ther; 2004 Nov; 11(22):1611-6. PubMed ID: 15385950
[TBL] [Abstract][Full Text] [Related]
5. Germline gene therapy?
Latchman DS
Gene Ther; 1994 Sep; 1(5):277-9. PubMed ID: 7584092
[No Abstract] [Full Text] [Related]
6. The ethics of gene therapy.
Chan S; Harris J
Curr Opin Mol Ther; 2006 Oct; 8(5):377-83. PubMed ID: 17078379
[TBL] [Abstract][Full Text] [Related]
7. Enhancement and human nature: the case of Sandel.
Lewens T
J Med Ethics; 2009 Jun; 35(6):354-6. PubMed ID: 19482977
[TBL] [Abstract][Full Text] [Related]
8. Enhancement is good for you!: understanding the ethics of genetic enhancement.
Harris J; Chan S
Gene Ther; 2008 Mar; 15(5):338-9. PubMed ID: 18283288
[No Abstract] [Full Text] [Related]
9. Gene therapy. Principles and potential applications.
Amor D
Aust Fam Physician; 2001 Oct; 30(10):953-8. PubMed ID: 11706603
[TBL] [Abstract][Full Text] [Related]
10. Ethical consideration.
Fuchs M
Methods Mol Biol; 2011; 737():407-24. PubMed ID: 21590407
[TBL] [Abstract][Full Text] [Related]
11. Gene doping: a review of performance-enhancing genetics.
Gaffney GR; Parisotto R
Pediatr Clin North Am; 2007 Aug; 54(4):807-22, xii-xiii. PubMed ID: 17723879
[TBL] [Abstract][Full Text] [Related]
12. Equality and the treatment-enhancement distinction.
Holtug N
Bioethics; 2011 Mar; 25(3):137-44. PubMed ID: 19659850
[TBL] [Abstract][Full Text] [Related]
13. Genethics. Gene therapy or genetic enhancement: does it make a difference?
Ethics Standards
Virtual Mentor; 2001 Feb; ():E5. PubMed ID: 15612129
[No Abstract] [Full Text] [Related]
14. Human growth hormone and the temptations of biomedical enhancement.
Conrad P; Potter D
Sociol Health Illn; 2004 Mar; 26(2):184-215. PubMed ID: 15027984
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy: the dawn of a revolution.
Greener M
Prof Nurse; 1993 Sep; 8(12):784-7. PubMed ID: 8367506
[TBL] [Abstract][Full Text] [Related]
16. Challenges of the new biotechnology.
Charlesworth M
Australas Cathol Rec; 1989 Jan; 66(1):67-82. PubMed ID: 16998987
[No Abstract] [Full Text] [Related]
17. Genes and athletes.
Patel DR; Greydanus DE
Adolesc Med; 2002 Jun; 13(2):249-55, v. PubMed ID: 11986034
[TBL] [Abstract][Full Text] [Related]
18. Imagining human enhancement: whose future, which rationality?
Tomasini F
Theor Med Bioeth; 2007; 28(6):497-507. PubMed ID: 18322820
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy for muscular dystrophy: current progress and future prospects.
Trollet C; Athanasopoulos T; Popplewell L; Malerba A; Dickson G
Expert Opin Biol Ther; 2009 Jul; 9(7):849-66. PubMed ID: 19527108
[TBL] [Abstract][Full Text] [Related]
20. Cat and mouse in regulating genetic 'enhancement'.
Miller H
Nat Biotechnol; 2005 Feb; 23(2):171-2. PubMed ID: 15696141
[No Abstract] [Full Text] [Related]
[Next] [New Search]
